
Shree Ganesh Remedies Share Price
₹738.00 +8.8 (1.21%)
10 Mar, 2025 18:18
Start SIP in
SGRL
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
Investment Returns
- Over 1 Month -7.12%
- Over 3 Month + 2.46%
- Over 6 Month -15.41%
- Over 1 Year + 9.23%
Smart Investing Starts Here Start SIP with Shree Ganesh Remedies for Steady Growth!
Shree Ganesh Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Shree Ganesh Remedies Financials
Shree Ganesh Remedies Technicals
EMA & SMA
Current Price
₹738.00
+
8.8
(1.21%)

-
- Bearish Moving Average 4
-
- Bullish Moving Average 12
- 20 Day
- ₹729.24
- 50 Day
- ₹733.08
- 100 Day
- ₹737.48
- 200 Day
- ₹728.14
Resistance and Support
730.35
- R3 780.55
- R2 764.20
- R1 746.70
- S1 712.85
- S2 696.50
- S3 679.00
Shree Ganesh Remedies Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-05 | Quarterly Results | |
2024-10-29 | Quarterly Results | |
2024-09-28 | Others | Inter alia, to consider forfeiture of Partly Paid-up Equity Shares issued on Rights basis, on which the holders thereof have failed to pay the balance call money within the stipulated timeline. issue of equity shares of Rs. 10/- in the ratio of 7:100 @ premium of Rs. 215/-. |
2024-08-12 | Quarterly Results | |
2024-06-01 | Audited Resutls | (Revised) issue of equity shares of Rs. 10/- in the ratio of 7:100 @ premium of Rs. 215/-. |
Shree Ganesh Remedies F&O
About Shree Ganesh Remedies
- NSE Symbol
- SGRL
- BSE Symbol
- 540737
- ISIN
- INE414Y01015
Similar Stocks to Shree Ganesh Remedies
Shree Ganesh Remedies FAQs
Shree Ganesh Remedies share price is ₹738 As on 10 March, 2025 | 18:04
The Market Cap of Shree Ganesh Remedies is ₹948.1 Cr As on 10 March, 2025 | 18:04
The P/E ratio of Shree Ganesh Remedies is 32.6 As on 10 March, 2025 | 18:04
The PB ratio of Shree Ganesh Remedies is 7.1 As on 10 March, 2025 | 18:04
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.